目的 對衡陽市中心醫(yī)院泌尿生殖系統(tǒng)藥物的使用情況進(jìn)行分析，為臨床合理用藥提供參考。方法 對2014-2016年衡陽市中心醫(yī)院泌尿生殖系統(tǒng)藥物的種類、銷售金額、用藥頻度（DDDs）、限定日費用（DDC）和排序比（B/A）等進(jìn)行統(tǒng)計分析。結(jié)果 2014-2016年泌尿生殖系統(tǒng)藥物的種類、銷售金額、構(gòu)成比和DDDs基本不變。中成藥的品種數(shù)、銷售金額和DDDs均排名第一；而婦科用抗感染藥和滅菌藥構(gòu)成比最小。DDDs一直排名前10的藥物有螺內(nèi)酯片、鹽酸坦洛新緩釋片、滋腎健腦液、保婦康栓、呋塞米片、百艾洗液、非那雄胺片7個品種。呋塞米片、氫氯噻嗪片、螺內(nèi)酯片各年DDC均較低，2014-2016年DDC最高的藥物分別是來曲唑片和復(fù)方大紅袍止血片。非那雄胺片/分散片、托拉塞米片、戊酸雌二醇片、氫氯噻嗪片、呋塞米注射液這5種藥物的B/A接近于1.0。結(jié)論 衡陽市中心醫(yī)院泌尿生殖系統(tǒng)藥物的使用基本合理，中成藥一直占據(jù)重要地位，臨床治療中應(yīng)根據(jù)患者的具體情況合理選擇藥物，以提高治療的安全性、有效性和經(jīng)濟性。

Objective To analyze the utilization of genitourinary system drugs in Hengyang Central Hospital, and in order to provide reference for clinical rational use of drugs. Methods Varieties, consumption sum, frequency of drug use (DDDs), defined daily cost (DDC), and sequence ratio (B/A) of genitourinary system drugs in Hengyang Central Hospital from 2014 to 2016 were statistically analyzed. Results Varieties, consumption sum, constituent ratio, and DDDs showed a stable tendency from 2014 to 2016. Variety number, consumption sum, and DDDs of Chinese patent medicine dominated the first places for 3 years, while the constituent ratio of gynecological antiinfectives and antiseptics always ranked the last. Spironolactone Tablets, Tamsulosin Hydrochloride Sustained Release Tablets, Zishen Jiannao Oral Liquid, Baofukang Shuan, Furosemide Tablets, Multi-love Lotion, and Finasteride Tablets ranked the top 10. DDC of Furosemide Tablets, Hydrochlorothiazide Tablets, and Spironolactone Tablets were low in every year. DDC of Letrozol Tablets and Fufang Dahongpao Zhixue Tablets for injection were the highest from 2014 to 2016. B/A of Finasteride Tablets/Dispersible Tablets, Torasemide Tablets, Estradiol Valerate Tablets, Hydrochlorothiazide Tablets, and Furosemide Injection were near to 1.0. Conclusion The utilization of genitourinary system drugs is basically rational in Hengyang Central Hospital. Chinese patent medicine have occupied the most important position among genitourinary system drugs. The drugs should be selected reasonably according to the specific condition of patients in clinical treatment, in order to improve the safety, effectiveness, and economy of treatment.